Healthy Skepticism Library item: 657

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Schubert T.
Risks and benefits of calcium antagonists.
Lancet 1995 Oct 7; 346:(8980):961

Keywords:
*letter to the editor disinformation Bayer European Society of Cardiology calcium channel blockers conflict of interest press conferences and releases industry perspective PROMOTION DISGUISED: DISINFORMATION AND HARASSMENT

Notes:

Bayer never tried to influence the hot line press conference at the European Society of Cardiology meeting. In view of the concerns raised in recent publications and presentations, it was natural and correct that we should wish to encourage a balanced debate.